CANSEARCH officially received the European Horizon 2020 grant in order to open the SIOPEL liver tumor research program in Switzerland (Hepatoblastoma, Hepatocarcinoma, clinical study CHILTERN-PHITT trial, SPOG as a national sponsor). Geneva is also the national IP of this study which is excellent for the management of oncological liver diseases in Switzerland.